Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Insight Lifetech is a leading Chinese medical technology company specializing in cardiovascular interventional devices. The company focuses on providing advanced solutions for coronary artery disease diagnosis and treatment, including Fractional Flow Reserve (FFR) systems and Intravascular Ultrasound (IVUS) imaging. Their flagship products, such as the TruePhysio FFR system and the VivoHeart IVUS system, are designed to improve clinical outcomes in percutaneous coronary interventions (PCI). Insight Lifetech is recognized for its innovation in integrating physiology and imaging into a single platform to guide precision medicine in cardiology. Headquartered in Shenzhen, the company has successfully commercialized its products in both domestic and international markets, including Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen City North Credibility.